Lifevantage (NASDAQ:LFVN) Stock Passes Below Two Hundred Day Moving Average – Should You Sell?
by Amy Steele · The Cerbat GemLifevantage Corporation (NASDAQ:LFVN – Get Free Report) passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $6.04 and traded as low as $4.71. Lifevantage shares last traded at $4.96, with a volume of 923,481 shares traded.
Analyst Ratings Changes
A number of analysts recently weighed in on the stock. Lake Street Capital restated a “buy” rating on shares of Lifevantage in a report on Thursday, February 5th. Loop Capital set a $5.00 price objective on Lifevantage in a research report on Thursday, February 5th. Finally, Weiss Ratings reissued a “hold (c)” rating on shares of Lifevantage in a research note on Friday, March 27th. One equities research analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $5.00.
Get Our Latest Stock Report on LFVN
Lifevantage Stock Up 2.4%
The firm’s 50-day moving average price is $4.64 and its two-hundred day moving average price is $6.01. The firm has a market capitalization of $65.07 million, a PE ratio of 8.47 and a beta of 0.36.
Lifevantage (NASDAQ:LFVN – Get Free Report) last posted its quarterly earnings data on Wednesday, February 4th. The company reported $0.15 EPS for the quarter, missing analysts’ consensus estimates of $0.22 by ($0.07). Lifevantage had a return on equity of 29.59% and a net margin of 3.74%.The firm had revenue of $48.93 million during the quarter, compared to analyst estimates of $54.40 million. Lifevantage has set its FY 2026 guidance at 0.600-0.800 EPS. Equities research analysts forecast that Lifevantage Corporation will post 0.65 EPS for the current year.
Lifevantage Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Monday, March 16th. Investors of record on Monday, March 2nd were paid a $0.045 dividend. This represents a $0.18 annualized dividend and a yield of 3.5%. The ex-dividend date of this dividend was Monday, March 2nd. Lifevantage’s dividend payout ratio is currently 30.00%.
Insiders Place Their Bets
In related news, Director Judd Dayton purchased 18,097 shares of Lifevantage stock in a transaction dated Friday, February 27th. The stock was acquired at an average cost of $4.63 per share, with a total value of $83,789.11. Following the completion of the transaction, the director directly owned 69,859 shares of the company’s stock, valued at $323,447.17. This trade represents a 34.96% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Over the last 90 days, insiders bought 38,207 shares of company stock worth $178,585. Insiders own 21.95% of the company’s stock.
Institutional Inflows and Outflows
Several large investors have recently added to or reduced their stakes in the stock. Cubist Systematic Strategies LLC purchased a new stake in Lifevantage in the 1st quarter worth approximately $97,000. Jones Financial Companies Lllp grew its holdings in shares of Lifevantage by 14,484.0% during the 1st quarter. Jones Financial Companies Lllp now owns 29,168 shares of the company’s stock valued at $425,000 after acquiring an additional 28,968 shares in the last quarter. Goldman Sachs Group Inc. increased its stake in shares of Lifevantage by 24.5% in the first quarter. Goldman Sachs Group Inc. now owns 44,518 shares of the company’s stock worth $649,000 after acquiring an additional 8,762 shares during the last quarter. Jane Street Group LLC raised its holdings in shares of Lifevantage by 5.4% during the first quarter. Jane Street Group LLC now owns 36,567 shares of the company’s stock worth $533,000 after acquiring an additional 1,877 shares in the last quarter. Finally, Geode Capital Management LLC raised its holdings in shares of Lifevantage by 106.1% during the second quarter. Geode Capital Management LLC now owns 245,332 shares of the company’s stock worth $3,210,000 after acquiring an additional 126,274 shares in the last quarter. Institutional investors and hedge funds own 35.32% of the company’s stock.
About Lifevantage
LifeVantage Corporation is a publicly traded company that develops, markets and distributes nutritional supplements, skincare products and weight-management solutions through a direct-selling business model. The company’s flagship offering, Protandim®, is formulated to activate the Nrf2 pathway, which is associated with cellular defense processes. LifeVantage also markets the PhysIQ® line for metabolism and body composition support and the TrueScience® skincare regimen, targeting a range of health and wellness needs.
Founded in 1999 and headquartered in Sandy, Utah, LifeVantage combines research in nutrigenomics with a network of independent distributors to bring its products to market.